Olsen, Tobias H.
Abanades, Brennan
Moal, Iain H.
Deane, Charlotte M. http://orcid.org/0000-0003-1388-2252
Funding for this research was provided by:
RCUK | Engineering and Physical Sciences Research Council (EP/S024093/1)
GlaxoSmithKline (EP/S024093/1)
Roche
GlaxoSmithKline
Article History
Received: 17 March 2023
Accepted: 3 July 2023
First Online: 18 July 2023
Competing interests
: Author IM is employed by GlaxoSmithKline plc and author CD is employed by Exscientia plc. All authors declare no other competing interests.